Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",blood aspartate transaminase amount,serum aspartate aminotransferase,RS:0001789,BDIX/CrCrl,male,71 days,10,,CMO:0000581,serum aspartate aminotransferase activity level,,,,139,U/l,2.5931,8.2,MMO:0000554,automated serum analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) ,107902,DHD/K12/TRb cells (1.5 X 10E6) ,vehicle control condition (1 ml) 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",blood aspartate transaminase amount,serum aspartate aminotransferase,RS:0001789,BDIX/CrCrl,male,92 days,10,,CMO:0000581,serum aspartate aminotransferase activity level,,,,193,U/l,8.2219,26.0,MMO:0000554,automated serum analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) ,107904,DHD/K12/TRb cells (1.5 X 10E6) ,vehicle control condition (1 ml)